rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-3-3
|
pubmed:abstractText |
To determine if systematic use of metoclopramide associated with opioids (Morphine sulfate SR) decreases the incidence of nausea and vomiting (N&V), established adverse effects of opioids.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-5957
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
446-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12611198-Aged,
pubmed-meshheading:12611198-Analgesics, Opioid,
pubmed-meshheading:12611198-Antiemetics,
pubmed-meshheading:12611198-Female,
pubmed-meshheading:12611198-Humans,
pubmed-meshheading:12611198-Male,
pubmed-meshheading:12611198-Metoclopramide,
pubmed-meshheading:12611198-Middle Aged,
pubmed-meshheading:12611198-Morphine,
pubmed-meshheading:12611198-Nausea,
pubmed-meshheading:12611198-Pain,
pubmed-meshheading:12611198-Rheumatic Diseases,
pubmed-meshheading:12611198-Vomiting
|
pubmed:articleTitle |
[Preventive therapy for nausea and vomiting in patients on opioid therapy for non-malignant pain in rheumatology].
|
pubmed:affiliation |
Service de Rhumatologie et Thérapeutique, CHU Dupuytren, Limoges, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|